Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Public ClinicalTrials.gov record NCT03045120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03045120
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 118 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2017
- Primary completion
- Jun 19, 2022
- Completion
- Jun 19, 2022
- Last update posted
- Dec 20, 2022
2017 – 2022
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mount Sinai Hospital | Chicago | Illinois | 60608 | — |
| Alexian Brothers Medical Center | Elk Grove Village | Illinois | 60007 | — |
| The Cancer Institute At Alexian Brothers | Elk Grove Village | Illinois | 60007 | — |
| Northwest Oncology & Hematology, SC | Hoffman Estates | Illinois | 60169 | — |
| Hematology/Oncology Of The North Shore | Lake Forest | Illinois | 60045 | — |
| Northwest Oncology & Hematology, SC | Rolling Meadows | Illinois | 60008 | — |
| Healthcare Research Network III, LLC | Tinley Park | Illinois | 60487 | — |
| American Health Network | Avon | Indiana | 46123 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| Hazard Arh Regional Medical Center | Hazard | Kentucky | 41701 | — |
| St. Agnes Hospital | Baltimore | Maryland | 21229 | — |
| St Vincent Frontier Cancer Center | Billings | Montana | 59102 | — |
| Local Institution - 0009 | Hackensack | New Jersey | 07601 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Weill Med Col Of Cornell | New York | New York | 10021 | — |
| Columbia University Medical Center (Cumc) | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Leo W.Jenkins Cancer Center | Greenville | North Carolina | 27834 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45202 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Huntsman Cancer Hospital | Salt Lake City | Utah | 84093 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
| Fred Hutchinson Can Res Ctr | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03045120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2022 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03045120 live on ClinicalTrials.gov.